BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17545592)

  • 1. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
    Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
    Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
    Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
    Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
    Du XL; Jiang T; Sheng XG; Gao R; Li QS
    Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
    Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
    APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
    Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
    Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
    Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
    Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of enhanced invasiveness of human hepatocellular carcinoma by integrin alpha 6 beta 1].
    Lu Y; Zhou R
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):287-9. PubMed ID: 11778551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
    Takafuji V; Forgues M; Unsworth E; Goldsmith P; Wang XW
    Oncogene; 2007 Sep; 26(44):6361-71. PubMed ID: 17452979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
    Yuan Z; Zheng Q; Huang XY; Fan J
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.